| Autor: |
John Cano, V. Pacheco-Barcia, S. Hernando Polo, Elena Asensio-Martínez, M. Antoñanzas Basa, L. Ostios García, Oscar García, N. Piera Molons, Patricia Cruz, Teófilo Zamarreño García, Caterina Calderon, M.H. Lopez De Ceballos, R. Hernandez, B. Obispo, David Lorente, M. Gonzalez Moya, A. Manzano Fernández, M. Gil Raga, Jacobo Rogado, A. Fernández Montes |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Annals of Oncology |
| ISSN: |
0923-7534 |
| Popis: |
Background: Cancer patients are at high risk of psychological problems and COVID-19 infection, which makes them even more vulnerable to mood disorders. Our objectives were to analyze the level of anxiety and depression among patients with advanced cancer during the COVID-19 pandemic and to analyze the association between sociodemographic, clinical, and psychological factors in patients with advanced cancer. Methods: A prospective, cross-sectional, multicenter study was conducted in 15 oncology departments in Spain. Patients with locally advanced unresectable or metastatic cancer who were candidates for systemic treatment were included. Patients completed demographic information and the Brief Symptom Inventory (BSI), Michel´s Uncertainty in Illness Scale (MUIS), Mental Adjustment to Cancer (MAC), and Cancer Worry Scale (CWS). Results: A total of 374 patients were recruited (April 2020-2021). The mean age was 64.2 years (34-88) and 48.7% were women. The most frequent were lung (30.7%) and colon (14.2%) cancers and most had metastases (78.6%). The most frequent therapy was chemotherapy (57.9%). The prevalence of anxiety and depression was 35% and 34%, respectively. Anxiety and depression levels were higher in women (p=0.001 and p=0.003, respectively). Patients 18 months (p=0.033) had more anxiety symptoms. Logistic regression analysis revealed that women, patients with coping based on anxious preoccupation and hopelessness had higher risk of anxiety and depression (all, p |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
